Cresco Labs Inc.
CRLBF- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001832928
No open-market purchases or sales by Cresco Labs Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $122.7K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cresco Labs Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 10 | 7 | −3 |
| Shares | 295.9K | 148.0K | −147.8K (−50.0%) |
| Value | $257.8K | $122.7K | −$135.1K (−52.4%) |
New holders (1)
Institutions that held Cresco Labs Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sterling Capital Management LLC | 132 | $110 | 0.00% |
Sold out (4)
Institutions that held Cresco Labs Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| First National Trust Co | 113,837 | $99.0K |
| Curio Wealth, LLC | 20,161 | $17.5K |
| Golden State Equity Partners | 1,300 | $1.13K |
| Hurley Capital, LLC | 1,014 | $882 |